Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic screens targeting neurodegenerative diseases.

Journal of biomolecular screening - 1 Jan 2014

Zhang Minhua, Luo Guangrui, Zhou Yanjiao, Wang Shaohui, Zhong Zhong

Abstract excerpt

Neurodegenerative diseases affect millions of people worldwide, and the incidences increase as the population ages. Disease-modifying therapy that prevents or slows disease progression is still lacking, making neurodegenerative diseases an area of high unmet medical need. Target-based drug discov...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Evaluation, Preclinical

Share to Neurodegenerative Diseases

Share to Neuroinflammation and Neurodegeneration Mechanisms

Share to Phenotype

Source

Identifiers

PMID: 23958650
DOI: 10.1177/1087057113499777

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23958650-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic screens targeting neurodegenerative diseases.PMID 23958650Read ↗

Phenotypic screening strategies for neurodegenerative diseases: a pathway to discover novel drug candidates and potential disease targets or mechanisms.Semantic proximity Read ↗

Cell death assays for neurodegenerative disease drug discoverySemantic proximity Read ↗

Phenotypic screens for compounds that target the cellular pathologies underlying Parkinson's disease.Semantic proximity Read ↗

Back to the future with phenotypic screening.Semantic proximity Read ↗

Promising Targets for the Treatment of Neurodegenerative DiseasesSemantic proximity Read ↗

Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration.Semantic proximity Read ↗

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s DiseasesSemantic proximity Read ↗

Next-generation neurotherapeutics: nanotechnology, immunotherapy, and gene editing for neurodegenerative diseasesSemantic proximity Read ↗

Hallmarks of neurodegenerative diseasesSemantic proximity Read ↗

High Throughput Screening for Neurodegeneration and Complex Disease PhenotypesSemantic proximity Read ↗

Toward stem cell-based phenotypic screens for neurodegenerative diseases.Semantic proximity Read ↗

Expanding therapeutic opportunities for neurodegenerative diseases: A perspective on the important role of phenotypic screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.